Vaxcyte Newsroom

Goldman Sachs Initiates Vaxcyte(PCVX.US) With Buy Rating, Announces Target Price $135

Futu NewsDec 21 02:31

Goldman Sachs Initiates Coverage On Vaxcyte With Buy Rating, Announces Price Target of $135

BenzingaDec 20 20:52

Vaxcyte Analyst Ratings

BenzingaDec 20 20:51

BofA Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Futu NewsNov 6 23:31

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $135

Futu NewsNov 6 21:37

BTIG Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $160

Futu NewsNov 6 20:31

Needham Maintains Vaxcyte(PCVX.US) With Buy Rating, Maintains Target Price $140

Futu NewsNov 6 19:33

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating, Announces Target Price $135

Futu NewsNov 6 09:32

Vaxcyte's Promising Clinical Advances and Strategic Plans Drive Buy Rating With $135 Price Target

TipRanksNov 6 09:07

Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Futu NewsOct 30 21:42

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Futu NewsOct 24 20:34

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Futu NewsOct 10 19:31

TD Cowen Reaffirms Their Buy Rating on Vaxcyte (PCVX)

TipRanksOct 10 19:17

Vaxcyte Is Maintained at Outperform by Mizuho

Dow JonesSep 10 21:52

Vaxcyte Analyst Ratings

BenzingaSep 10 21:44

Mizuho Securities Maintains Vaxcyte(PCVX.US) With Buy Rating

Futu NewsSep 10 19:33

TD Cowen Maintains Vaxcyte(PCVX.US) With Buy Rating

Futu NewsSep 5 19:35

Guggenheim Maintains Vaxcyte(PCVX.US) With Buy Rating, Raises Target Price to $130

Futu NewsSep 4 21:31

A Quick Look at Today's Ratings for Vaxcyte(PCVX.US), With a Forecast Between $113 to $160

Futu NewsSep 4 21:00

Vaxcyte Is Maintained at Buy by B of A Securities

Dow JonesSep 4 19:44